Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 5/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.47 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | GJB2 | P29033 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9724527 | 1.00 | GBA1 (0.56) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL9350378 | 1.00 | GBA1 (0.56) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL7529325 | 0.88 | LGALS3 (0.39) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL6221340 | 0.85 | LGALS8 (0.47) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL6816403 | 0.85 | LGALS8 (0.47) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL23646744 | 0.85 | GBA1 (0.59) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL258033 | 0.85 | GBA1 (0.59) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL9291634 | 0.85 | GBA1 (0.59) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL1134708 | 0.85 | GBA1 (0.59) | GBA1MAPK1LGALS8LGALS3LGALS4 | |
| SCHEMBL4912663 | 0.85 | GBA1 (0.59) | GBA1MAPK1LGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524510-B2 | Alkyl-glycoside enhanced vaccination | THE UAB RESEARCH FOUNDATION (US) | 2009-04-28 | — | — | US | claimed |
| EP-1863511-A2 | ALKYL-GLYCOSIDE ENHANCED VACCINATION | UAB Research Foundation (US) | 2007-12-12 | — | — | EP | claimed |
| US-20060233761-A1 | Noninvasive immunization; immunostimulants | UAB RESEARCH FOUNDATION, THE | 2006-10-19 | — | — | US | claimed |
| WO-2006091722-A2 | ALKYL-GLYCOSIDE ENHANCED VACCINATION | UAB RESEARCH FOUNDATION (US) | 2006-08-31 | — | — | WO | claimed |
| EP-0841954-B1 | METHOD FOR THE PRODUCTION OF VIRUSSAFE, THERAPEUTIC, BIOLOGICAL PREPARATIONS | BLUTSPENDEDIENST DER DRK LANDE (DE) | 1999-09-01 | — | — | EP | claimed |
| EP-0841954-B1 | METHOD FOR THE PRODUCTION OF VIRUSSAFE, THERAPEUTIC, BIOLOGICAL PREPARATIONS | BLUTSPENDEDIENST DER DRK LANDE (DE) | 1999-09-01 | — | — | EP | disclosed |